Clinical Trial Update: Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy [Phase 3]

View source ↗

Summary

Phase 3 usability study of auto-injector devices for patients with high cardiovascular risk and hypercholesterolemia, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolaemia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-09